Compare WGS & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WGS | CLMT |
|---|---|---|
| Founded | 2017 | 1916 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Oil & Gas Production |
| Sector | Technology | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | N/A | 2024 |
| Metric | WGS | CLMT |
|---|---|---|
| Price | $65.76 | $34.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $130.71 | $28.65 |
| AVG Volume (30 Days) | 628.4K | ★ 1.3M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,137,100,000.00 |
| Revenue This Year | $29.98 | $4.45 |
| Revenue Next Year | $25.92 | $0.58 |
| P/E Ratio | $1,251.58 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $55.17 | $8.63 |
| 52 Week High | $170.87 | $36.94 |
| Indicator | WGS | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 64.47 |
| Support Level | $61.55 | $17.58 |
| Resistance Level | $95.75 | $36.94 |
| Average True Range (ATR) | 4.01 | 1.84 |
| MACD | 0.81 | 0.32 |
| Stochastic Oscillator | 57.85 | 73.92 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.